Portneuf Medical Center, serving Southeastern Idaho, whose core mission is “World Class Care, Every patient, Every time," and Bingham Memorial Hospital, one of the leading and award-winning healthcare ...

Portneuf Medical Center, serving Southeastern Idaho, whose core mission is “World Class Care, Every patient, Every time," and Bingham Memorial Hospital, ...

Donna Rigby, a grandmother living in Asbury Park, New Jersey and a former licensed practical nurse (LPN), experienced a ...

Tempus AI's partnerships with NYU Langone and Northwestern Medicine aim to expand genomic testing and data-driven cancer care ...

In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.

Morgane Grappy, from East London, was diagnosed with rhabdomyosarcoma on July 19, 2024, after noticing a lump on the palm of ...

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

Labcorp , a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help clinicians ...

Alshehri, E. (2026) The Diagnostic Conundrum of Recurrent High-Grade Vaginal Intraepithelial Neoplasia (VAIN) Following ...

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.

New immune roadmaps help physicians detect cancer recurrence early and customize treatments to the body’s defenses, providing ...